| Angela B Shannon, MD | |
|
1679 Old Fannin Rd Ste E, Flowood, MS 39232-8101 | |
| (601) 398-1949 | |
| (769) 216-3044 |
| Full Name | Angela B Shannon |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Gastroenterology |
| Location | 1679 Old Fannin Rd Ste E, Flowood, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407067739 | NPI | - | NPPES |
| 05307227 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0206X | Pediatrics - Pediatric Gastroenterology | 22009 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Angela B Shannon, MD 1679 Old Fannin Rd Ste E, Flowood, MS 39232-8101 Ph: (601) 398-1949 | Angela B Shannon, MD 1679 Old Fannin Rd Ste E, Flowood, MS 39232-8101 Ph: (601) 398-1949 |
News Archive
Surviving breast cancer is both a physical and an emotional ordeal, but the consensus among researchers is that life generally returns to normal for most women within two years of completing treatment.
People who live in areas with lower household incomes are much more likely to die because of their personal and household characteristics and their community surroundings, according to Steven H. Woolf, M.D., M.P.H., director of the VCU Center on Human Needs, professor in the Department of Family Medicine and lead author of the study.
Over 90 per cent of physicians treating actinic keratosis (AK) prefer short duration treatment options with fast resolving local skin responses (LSRs), is the finding of a global study (‘Physician Perceptions and Experience of Current Treatment in Actinic Keratosis') that is being presented today at the 22nd Congress of the European Academy of Dermatology and Venereology (EADV).
From the Industrial Revolution and onward, the world has become an environment that is overflowing with dangerous toxins. Mass manufacturing has resulted in thousands of chemical pollutants being released in the atmosphere, water, and soil. As well, there has been a widespread increase of chemicals being added to almost every type of food and retail product.
BerGenBio AS today announced the start of a Phase 1 Clinical Trial for BGB324, a first-in-class small molecule inhibitor of AXL tyrosine kinase. BGB324 is a highly selective, oral AXL inhibitor that blocks the epithelial-mesenchymal transition (EMT), which is a key driver of metastasis (cancer spread) and drug-resistance. The Phase 1 clinical trial of BGB324 is a single ascending dose study designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of BGB324.
› Verified 9 days ago
Dr. Samuel A. Smith, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2946 Layfair Drive, Flowood, MS 39232 Phone: 601-420-8233 Fax: 601-936-5370 | |
David M Temple, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5 River Bend Place, Suite C, Flowood, MS 39232 Phone: 601-957-7345 Fax: 769-251-5429 | |
David F Wender, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5 River Bend Place, Suite C, Flowood, MS 39232 Phone: 601-975-7345 Fax: 769-251-5429 | |
Dr. Alisha Stockton Vaughn, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 151 E Metro Dr, Suite 102, Flowood, MS 39232 Phone: 601-992-2292 | |
Dr. Megan Lynn Washington, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 1020 River Oaks Dr, Ste 100, Flowood, MS 39232 Phone: 601-326-8700 Fax: 601-936-2252 | |
Carold Jason Miller, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5 River Bend Place, Suite C, Flowood, MS 39232 Phone: 601-957-7345 Fax: 769-251-5429 | |
Dr. Laura A. Barron, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2946 Layfair Drive, Flowood, MS 39232 Phone: 601-420-8233 Fax: 601-936-5370 |